<?xml version="1.0" encoding="UTF-8"?><mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="id-2016-15684">
    <name type="corporate">
        <namePart>United States Government Publishing Office</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
            <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
        <role>
            <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
            <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>National Archives and Records Administration</namePart>
        <namePart>Office of the Federal Register</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">author</roleTerm>
            <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
        <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
        <collectionCode>FR</collectionCode>
        <category>Regulatory Information</category>
        <waisDatabaseName>2016_register</waisDatabaseName>
        <branch>executive</branch>
        <dateIngested>2016-07-14</dateIngested>
    </extension>
    <genre authority="marcgt">article</genre>
    <titleInfo>
        <title>Submission of Food and Drug Administration Import Data in the Automated Commercial Environment</title>
        <partName>Proposed Rules</partName>
    </titleInfo>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2016-07-01/html/2016-15684.htm">
        <identifier type="FDsys Unique ID">D09002ee1c7f5e72d</identifier>
    </relatedItem>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2016-07-01/pdf/2016-15684.pdf">
        <identifier type="FDsys Unique ID">D09002ee1c7f5e7b8</identifier>
    </relatedItem>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Department of Health and Human Services</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Food and Drug Administration</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <abstract>The Food and Drug Administration (FDA, the Agency, or we) is proposing to establish requirements for the electronic filing of entries of FDA-regulated products in the Automated Commercial Environment (ACE) or any other electronic data interchange (EDI) system authorized by the U.S. Customs and Border Protection Agency (CBP), in order for the filing to be processed by CBP and to help FDA in determining admissibility of that product. ACE is a commercial trade processing system operated by CBP that is designed to implement the International Trade Data System (ITDS), automate import and export processing, enhance border security, foster U.S. economic security through lawful international trade and policy, and to replace the Automated Commercial System (ACS). FDA is a Partner Government Agency (PGA) in the initiative to establish ITDS, the "single window" for the submission of import and export data to the United States Government. The proposed rule would also update certain sections of FDA regulations related to imports. This rule, as proposed, does not affect the ability of filers to continue to submit their import entries and entry summaries by paper for FDA-regulated products that are being imported or offered for import. Once finalized, this action will facilitate effective and efficient admissibility review by the Agency and protect public health by allowing FDA to focus its limited resources on those FDA-regulated products being imported or offered for import that may be associated with a greater public health risk.</abstract>
    <identifier type="FR citation">81 FR 43155</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/FR-2016-07-01/2016-15684</identifier>
    <identifier type="FR Doc No.">2016-15684</identifier>
    <identifier type="former granule identifier">fr01jy16-42</identifier>
    <identifier type="billing code">4164-01-P</identifier>
    <identifier type="department code">Docket No. FDA-2016-N-1487</identifier>
    <location>
        <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2016-07-01/2016-15684</url>
        <url access="raw object" displayLabel="HTML rendition">https://www.govinfo.gov/content/pkg/FR-2016-07-01/html/2016-15684.htm</url>
        <url access="raw object" displayLabel="PDF rendition">https://www.govinfo.gov/content/pkg/FR-2016-07-01/pdf/2016-15684.pdf</url>
    </location>
    <subject>
        <topic>Cosmetics</topic>
        <topic>Drugs</topic>
        <topic>Exports</topic>
        <topic>Food Labeling</topic>
        <topic>Imports</topic>
        <topic>Labeling</topic>
        <topic>Reporting and Recordkeeping Requirements</topic>
        <topic>Administrative Practice and Procedure</topic>
        <topic>Electronic Products</topic>
        <topic>Radiation Protection</topic>
        <topic>Surety Bonds</topic>
        <topic>Biologics</topic>
        <topic>Human Cells and Tissue-Based Products</topic>
        <topic>Medical Devices</topic>
    </subject>
    <physicalDescription>
        <extent>24 p.</extent>
    </physicalDescription>
    <part type="Proposed Rules">
        <extent unit="pages">
            <start>43155</start>
            <end>43178</end>
        </extent>
    </part>
    <identifier type="preferred citation">81 FR 43155</identifier>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 1005</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  1005</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 1271</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  1271</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 1</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  1</identifier>
    </relatedItem>
    <extension>
        <searchTitle>Submission of Food and Drug Administration Import Data in the Automated Commercial Environment; Federal Register Vol. 81, Issue </searchTitle>
        <granuleClass>PRORULE</granuleClass>
        <accessId>2016-15684</accessId>
        <agency order="1">DEPARTMENT OF HEALTH AND HUMAN SERVICES</agency>
        <agency order="2">Food and Drug Administration</agency>
        <commentDate>2016-08-30</commentDate>
        <departmentDoc>Docket No. FDA-2016-N-1487</departmentDoc>
        <billingCode>4164-01-P</billingCode>
        <frDocNumber>2016-15684</frDocNumber>
        <action>Proposed rule.</action>
        <summary>The Food and Drug Administration (FDA, the Agency, or we) is proposing to establish requirements for the electronic filing of entries of FDA-regulated products in the Automated Commercial Environment (ACE) or any other electronic data interchange (EDI) system authorized by the U.S. Customs and Border Protection Agency (CBP), in order for the filing to be processed by CBP and to help FDA in determining admissibility of that product. ACE is a commercial trade processing system operated by CBP that is designed to implement the International Trade Data System (ITDS), automate import and export processing, enhance border security, foster U.S. economic security through lawful international trade and policy, and to replace the Automated Commercial System (ACS). FDA is a Partner Government Agency (PGA) in the initiative to establish ITDS, the "single window" for the submission of import and export data to the United States Government. The proposed rule would also update certain sections of FDA regulations related to imports. This rule, as proposed, does not affect the ability of filers to continue to submit their import entries and entry summaries by paper for FDA-regulated products that are being imported or offered for import. Once finalized, this action will facilitate effective and efficient admissibility review by the Agency and protect public health by allowing FDA to focus its limited resources on those FDA-regulated products being imported or offered for import that may be associated with a greater public health risk.</summary>
        <dates>Submit either electronic or written comments on the proposed rule by August 30, 2016.</dates>
        <contact>Ann M. Metayer, Office of Regulatory Affairs, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 4338, Silver Spring, MD 20993-0002, 301-796-3324, Ann.Metayer@fda.hhs.gov.</contact>
        <cfr title="21">
                                    
            <part number="1005"/>
                                
        </cfr>
        <cfr title="21">
                                    
            <part number="1271"/>
                                
        </cfr>
        <cfr title="21">
                                    
            <part number="1"/>
                                    
            <subject>Cosmetics</subject>
                                    
            <subject>Drugs</subject>
                                    
            <subject>Exports</subject>
                                    
            <subject>Food Labeling</subject>
                                    
            <subject>Imports</subject>
                                    
            <subject>Labeling</subject>
                                    
            <subject>Reporting and Recordkeeping Requirements</subject>
                                    
            <subject>Administrative Practice and Procedure</subject>
                                    
            <subject>Electronic Products</subject>
                                    
            <subject>Radiation Protection</subject>
                                    
            <subject>Surety Bonds</subject>
                                    
            <subject>Biologics</subject>
                                    
            <subject>Human Cells and Tissue-Based Products</subject>
                                    
            <subject>Medical Devices</subject>
                                
        </cfr>
        <tocDoc>Submission of Food and Drug Administration Import Data in the Automated Commercial Environment
, </tocDoc>
        <emailRef>Ann.Metayer@fda.hhs.gov</emailRef>
        <emailRef>Jonnalynn.Capezzuto@fda.hhs.gov</emailRef>
        <emailRef>oira_submission@omb.eop.gov</emailRef>
        <urlRef>http://www.accessdata.fda.gov/SCRIPTS/ORA/PCB/PCB.HTM</urlRef>
        <urlRef>http://www.cbp.gov/trade/acs/catair</urlRef>
        <urlRef>http://www.fda.gov/AboutFDA/ReportsManualsForms/Reports/EconomicAnalyses/default.htm</urlRef>
        <urlRef>http://www.fda.gov/AnimalVeterinary/DevelopmentApprovalProcess/MinorUseMinorSpecies/ucm125452.htm</urlRef>
        <urlRef>http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm490264.pdf</urlRef>
        <urlRef>http://www.fda.gov/downloads/ForIndustry/ImportProgram/UCM459926.pdf</urlRef>
        <urlRef>http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/ucm309376.htm</urlRef>
        <urlRef>http://www.fda.gov/forindustry/importprogram/entryprocess/entrysubmissionprocess/ucm461234.htm</urlRef>
        <urlRef>http://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf</urlRef>
        <urlRef>http://www.regulations.gov</urlRef>
        <urlRef>https://www.accessdata.fda.gov/scripts/cber/CFAppsPub/tiss/index.cfm</urlRef>
    </extension>
    <relatedItem type="host" ID="P0b002ee190426857" xlink:href="https://www.govinfo.gov/metadata/pkg/FR-2016-07-01/mods.xml">
        <titleInfo>
            <title>Federal Register</title>
            <partNumber>Vol. 81, no. 127</partNumber>
        </titleInfo>
        <originInfo>
            <publisher>Office of the Federal Register, National Archives and Records Administration</publisher>
            <dateIssued encoding="w3cdtf">2016-07-01</dateIssued>
            <issuance>continuing</issuance>
            <frequency>daily</frequency>
        </originInfo>
        <physicalDescription>
            <note type="source content type">deposited</note>
            <digitalOrigin>born digital</digitalOrigin>
            <extent>490 p.</extent>
        </physicalDescription>
        <tableOfContents xlink:href="https://www.govinfo.gov/app/frtoc/2016-07-01">    
		  Table of Contents: 
		</tableOfContents>
        <classification authority="sudocs">AE 2.7:</classification>
        <classification authority="sudocs">GS 4.107:</classification>
        <classification authority="sudocs">AE 2.106:</classification>
        <classification authority="lcc">KF70.A2</classification>
        <identifier type="uri">https://www.govinfo.gov/app/details/FR-2016-07-01</identifier>
        <identifier type="local">P0b002ee190426857</identifier>
        <identifier type="issn">0097-6326</identifier>
        <identifier type="issn">0042-1219</identifier>
        <identifier type="issn">0364-1406</identifier>
        <identifier type="stock number">769-004-00000-9</identifier>
        <identifier type="ILS system id">000582072</identifier>
        <identifier type="former identifier">f:fr01jy16</identifier>
        <location>
            <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2016-07-01</url>
            <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2016-07-01/pdf/FR-2016-07-01.pdf</url>
            <url displayLabel="XML rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2016-07-01/xml/FR-2016-07-01.xml</url>
        </location>
        <accessCondition type="GPO scope determination">fdlp</accessCondition>
        <part type="issue">
            <extent unit="pages">
                <start>42983</start>
                <end>43461</end>
            </extent>
        </part>
        <recordInfo>
            <recordContentSource authority="marcorg">DGPO</recordContentSource>
            <recordCreationDate encoding="w3cdtf">2016-07-14</recordCreationDate>
            <recordChangeDate encoding="w3cdtf">2024-06-01</recordChangeDate>
            <recordIdentifier source="DGPO">FR-2016-07-01</recordIdentifier>
            <recordOrigin>machine generated</recordOrigin>
            <languageOfCataloging>
                <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
            </languageOfCataloging>
        </recordInfo>
        <extension>
            <docClass>FR</docClass>
            <accessId>FR-2016-07-01</accessId>
            <volume>81</volume>
            <issue>127</issue>
        </extension>
    </relatedItem>
</mods>
